EGF Theramed Health Corp.

Equities

TMED

CA2684692023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 09:56:38 2024-05-16 am EDT			5-day change	1st Jan Change
0.145 ^CAD	+3.57%		+3.57%	-23.68%

Feb. 26	EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Egf Theramed Health Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2020

February 25, 2021

EGF Theramed Health Corp. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced operating loss was CAD 265,442 compared to CAD 299,969 a year ago. Net loss was CAD 235,437 compared to CAD 281,669 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.24 a year ago. For the half year, operating loss was CAD 505,168 compared to CAD 859,691 a year ago. Net loss was CAD 457,487 compared to CAD 1.102 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 1.09 a year ago.

Latest news about EGF Theramed Health Corp.

EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 26	CI
EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 27	CI
EGF Theramed Health Corp. entered into a Letter of Intent to acquire Nanaimo Dispensary from Kiaro Holdings Corp. (TSXV:KO) for CAD 0.12 million.	23-10-29	CI
EGF Theramed Health Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-29	CI
EGF Theramed Health Corp. Announces Board Changes	23-07-07	CI
EGF Theramed Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-29	CI
EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-27	CI
EGF Theramed Health Corp. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-29	CI
EGF Theramed Health Corp. Reports Earnings Results for the Full Year Ended June 30, 2022	22-10-28	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	22-10-27	CI
EGF Theramed Health Corp. Announces Resignation of Jatinder Dhaliwal as Director	22-08-18	CI
EGF Theramed Health Corp. Announces Executive Changes	22-08-18	CI
EGF Theramed Health Corp. entered into a term sheet to acquire Reefer Keeper Delivery Corp. for CAD 0.96 million.	22-08-16	CI
EGF Theramed Health Corp. announced that it has received CAD 0.5 million in funding	22-07-21	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.5 million in funding	22-07-17	CI
EGF Theramed Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-30	CI
EGF Theramed Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-27	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	21-10-31	CI
EGF Theramed Health Corp. Auditor Raises 'Going Concern' Doubt	21-08-19	CI
EGF Theramed Health Corp. announced that it has received CAD 0.25 million in funding	21-07-13	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.4 million in funding	21-06-27	CI
EGF Theramed Health Corp. announced that it has received CAD 0.2 million in funding	21-06-22	CI
Seedadelic Med Corp. completed the acquisition of EGF Theramed Health Corp. in a reverse merger transaction.	21-06-06	CI
EGF Theramed Health Corp. announced that it expects to receive CAD 0.2 million in funding	21-06-02	CI
Egf Theramed Health Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-30	CI

Chart EGF Theramed Health Corp.

Duration

Period

More charts

Company Profile

EGF Theramed Health Corp. is a Canada-based consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs. The Company is focused on developing products, technologies, and diagnostic tools in personalized medical care areas, including research with natural health and wellness products. The Company is focused on the health care and life sciences sector to develop a personalized health care system. The Company is also exploring opportunities in all medical areas in domestic and international markets. Its portfolio includes Pharmadelic Labs and Green Parrot Labs.

Sector

Biotechnology & Medical Research

Calendar

2024-05-27 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EGF THERAMED HEALTH CORP.	-23.68%	1.17M
MODERNA, INC.	+64.92%	62.59B
IQVIA HOLDINGS INC.	-1.85%	41.18B
LONZA GROUP AG	+44.76%	40.29B
CELLTRION, INC.	-8.93%	27.9B
ICON PUBLIC LIMITED COMPANY	+13.05%	26.21B
ALNYLAM PHARMACEUTICALS, INC.	-21.96%	19.09B
BIO-TECHNE CORPORATION	+4.21%	13.08B
UNITED THERAPEUTICS CORPORATION	+25.74%	12.26B
MEDPACE HOLDINGS, INC.	+27.42%	12.05B

Other Biotechnology & Medical Research